CRANE CO (CR) Stock Fundamental Analysis
NYSE:CR - New York Stock Exchange, Inc. - US2244081046 - Common Stock - Currency: USD
Overall CR gets a fundamental rating of 6 out of 10. We evaluated CR against 128 industry peers in the Machinery industry. CR scores excellent points on both the profitability and health parts. This is a solid base for a good stock. While showing a medium growth rate, CR is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
CR had positive earnings in the past year.
CR had a positive operating cash flow in the past year.
Each year in the past 5 years CR has been profitable.
CR had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 12.85%, CR belongs to the top of the industry, outperforming 89.84% of the companies in the same industry.
CR has a better Return On Equity (19.18%) than 80.47% of its industry peers.
CR's Return On Invested Capital of 14.48% is amongst the best of the industry. CR outperforms 83.59% of its industry peers.
CR had an Average Return On Invested Capital over the past 3 years of 9.11%. This is in line with the industry average of 10.72%.
The last Return On Invested Capital (14.48%) for CR is above the 3 year average (9.11%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.85% | ||
| ROE | 19.18% | ||
| ROIC | 14.48% |
ROA(3y)10.39%
ROA(5y)10.5%
ROE(3y)19.31%
ROE(5y)22.01%
ROIC(3y)9.11%
ROIC(5y)8.41%
1.3 Margins
With an excellent Profit Margin value of 15.87%, CR belongs to the best of the industry, outperforming 89.06% of the companies in the same industry.
CR's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 17.31%, CR belongs to the top of the industry, outperforming 81.25% of the companies in the same industry.
CR's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 41.67%, CR is in the better half of the industry, outperforming 77.34% of the companies in the same industry.
In the last couple of years the Gross Margin of CR has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.31% | ||
| PM (TTM) | 15.87% | ||
| GM | 41.67% |
OM growth 3Y15.82%
OM growth 5Y3.47%
PM growth 3Y-13.15%
PM growth 5Y27.77%
GM growth 3Y6.84%
GM growth 5Y2.54%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CR is creating some value.
Compared to 1 year ago, CR has more shares outstanding
The number of shares outstanding for CR has been reduced compared to 5 years ago.
The debt/assets ratio for CR has been reduced compared to a year ago.
2.2 Solvency
CR has an Altman-Z score of 9.43. This indicates that CR is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CR (9.43) is better than 94.53% of its industry peers.
There is no outstanding debt for CR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.94 | ||
| Altman-Z | 9.43 |
ROIC/WACC1.43
WACC10.11%
2.3 Liquidity
A Current Ratio of 2.08 indicates that CR has no problem at all paying its short term obligations.
The Current ratio of CR (2.08) is comparable to the rest of the industry.
CR has a Quick Ratio of 1.49. This is a normal value and indicates that CR is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.49, CR is in the better half of the industry, outperforming 64.84% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.08 | ||
| Quick Ratio | 1.49 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 25.41% over the past year.
CR shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.00% yearly.
CR shows a decrease in Revenue. In the last year, the revenue decreased by -0.67%.
The Revenue has been decreasing by -8.28% on average over the past years.
EPS 1Y (TTM)25.41%
EPS 3Y-8.02%
EPS 5Y-3%
EPS Q2Q%13.93%
Revenue 1Y (TTM)-0.67%
Revenue growth 3Y1.09%
Revenue growth 5Y-8.28%
Sales Q2Q%-1.36%
3.2 Future
CR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.85% yearly.
CR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.61% yearly.
EPS Next Y10.51%
EPS Next 2Y12.53%
EPS Next 3Y13.49%
EPS Next 5Y11.85%
Revenue Next Year6.34%
Revenue Next 2Y8.68%
Revenue Next 3Y9.18%
Revenue Next 5Y6.61%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 33.55, the valuation of CR can be described as expensive.
65.63% of the companies in the same industry are cheaper than CR, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.35. CR is valued slightly more expensive when compared to this.
Based on the Price/Forward Earnings ratio of 27.36, the valuation of CR can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CR indicates a slightly more expensive valuation: CR is more expensive than 65.63% of the companies listed in the same industry.
CR is valuated rather expensively when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.55 | ||
| Fwd PE | 27.36 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CR is valued a bit more expensive than 70.31% of the companies in the same industry.
64.06% of the companies in the same industry are cheaper than CR, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 39.3 | ||
| EV/EBITDA | 24.14 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CR has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CR's earnings are expected to grow with 13.49% in the coming years.
PEG (NY)3.19
PEG (5Y)N/A
EPS Next 2Y12.53%
EPS Next 3Y13.49%
5. Dividend
5.1 Amount
CR has a yearly dividend return of 0.49%, which is pretty low.
CR's Dividend Yield is comparable with the industry average which is at 1.93.
With a Dividend Yield of 0.49, CR pays less dividend than the S&P500 average, which is at 2.42.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.49% |
5.2 History
The dividend of CR decreases each year by -12.19%.
CR has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-12.19%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
CR pays out 14.36% of its income as dividend. This is a sustainable payout ratio.
DP14.36%
EPS Next 2Y12.53%
EPS Next 3Y13.49%
178.8
+0.4 (+0.22%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners76.14%
Inst Owner Change0%
Ins Owners0.27%
Ins Owner Change0.55%
Market Cap10.28B
Analysts82.35
Price Target195.87 (9.55%)
Short Float %1.31%
Short Ratio1.93
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.49% |
Yearly Dividend0.82
Dividend Growth(5Y)-12.19%
DP14.36%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.76%
Min EPS beat(2)0.24%
Max EPS beat(2)3.28%
EPS beat(4)4
Avg EPS beat(4)1.71%
Min EPS beat(4)0.24%
Max EPS beat(4)3.28%
EPS beat(8)8
Avg EPS beat(8)6.03%
EPS beat(12)11
Avg EPS beat(12)8.46%
EPS beat(16)15
Avg EPS beat(16)10.95%
Revenue beat(2)0
Avg Revenue beat(2)-1.14%
Min Revenue beat(2)-1.2%
Max Revenue beat(2)-1.07%
Revenue beat(4)0
Avg Revenue beat(4)-1.36%
Min Revenue beat(4)-2.46%
Max Revenue beat(4)-0.71%
Revenue beat(8)2
Avg Revenue beat(8)-1.01%
Revenue beat(12)5
Avg Revenue beat(12)3.19%
Revenue beat(16)7
Avg Revenue beat(16)1.16%
PT rev (1m)5.42%
PT rev (3m)2.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.65%
EPS NY rev (1m)0.98%
EPS NY rev (3m)0.14%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.83%
Revenue NY rev (1m)0.3%
Revenue NY rev (3m)0.86%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.55 | ||
| Fwd PE | 27.36 | ||
| P/S | 4.84 | ||
| P/FCF | 39.3 | ||
| P/OCF | 33.9 | ||
| P/B | 5.85 | ||
| P/tB | 11.05 | ||
| EV/EBITDA | 24.14 |
EPS(TTM)5.33
EY2.98%
EPS(NY)6.53
Fwd EY3.65%
FCF(TTM)4.55
FCFY2.54%
OCF(TTM)5.27
OCFY2.95%
SpS36.93
BVpS30.55
TBVpS16.18
PEG (NY)3.19
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.85% | ||
| ROE | 19.18% | ||
| ROCE | 18.73% | ||
| ROIC | 14.48% | ||
| ROICexc | 18.61% | ||
| ROICexgc | 40.56% | ||
| OM | 17.31% | ||
| PM (TTM) | 15.87% | ||
| GM | 41.67% | ||
| FCFM | 12.32% |
ROA(3y)10.39%
ROA(5y)10.5%
ROE(3y)19.31%
ROE(5y)22.01%
ROIC(3y)9.11%
ROIC(5y)8.41%
ROICexc(3y)10.78%
ROICexc(5y)10.01%
ROICexgc(3y)18.74%
ROICexgc(5y)19.36%
ROCE(3y)12.01%
ROCE(5y)11.18%
ROICexcg growth 3Y10.29%
ROICexcg growth 5Y0.39%
ROICexc growth 3Y13.04%
ROICexc growth 5Y6.99%
OM growth 3Y15.82%
OM growth 5Y3.47%
PM growth 3Y-13.15%
PM growth 5Y27.77%
GM growth 3Y6.84%
GM growth 5Y2.54%
F-Score6
Asset Turnover0.81
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.94 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 82.41% | ||
| Cap/Sales | 1.96% | ||
| Interest Coverage | 16.41 | ||
| Cash Conversion | 72.54% | ||
| Profit Quality | 77.63% | ||
| Current Ratio | 2.08 | ||
| Quick Ratio | 1.49 | ||
| Altman-Z | 9.43 |
F-Score6
WACC10.11%
ROIC/WACC1.43
Cap/Depr(3y)93.58%
Cap/Depr(5y)79.88%
Cap/Sales(3y)1.9%
Cap/Sales(5y)1.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.41%
EPS 3Y-8.02%
EPS 5Y-3%
EPS Q2Q%13.93%
EPS Next Y10.51%
EPS Next 2Y12.53%
EPS Next 3Y13.49%
EPS Next 5Y11.85%
Revenue 1Y (TTM)-0.67%
Revenue growth 3Y1.09%
Revenue growth 5Y-8.28%
Sales Q2Q%-1.36%
Revenue Next Year6.34%
Revenue Next 2Y8.68%
Revenue Next 3Y9.18%
Revenue Next 5Y6.61%
EBIT growth 1Y24.28%
EBIT growth 3Y17.08%
EBIT growth 5Y-5.09%
EBIT Next Year23.98%
EBIT Next 3Y15.27%
EBIT Next 5Y12.57%
FCF growth 1Y151.25%
FCF growth 3Y-20.47%
FCF growth 5Y-6.44%
OCF growth 1Y163.6%
OCF growth 3Y-18.53%
OCF growth 5Y-7.3%